Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176


Supporting Providers After Drug Overdose Death.

Yule AM, Levin FR.

Am J Psychiatry. 2019 Mar 1;176(3):173-178. doi: 10.1176/appi.ajp.2018.18070794. No abstract available.


Deficient Functioning of Fronto-Striatal Circuits During the Resolution of Cognitive Conflict in Cannabis-Using Youth.

Cyr M, Tau GZ, Fontaine M, Levin FR, Marsh R.

J Am Acad Child Adolesc Psychiatry. 2018 Oct 30. pii: S0890-8567(18)31910-5. doi: 10.1016/j.jaac.2018.09.436. [Epub ahead of print]


Beth Macy's Dopesick.

Williams AR, Levin FR.

Cerebrum. 2018 Nov 1;2018. pii: cer-15-18. eCollection 2018 Nov-Dec.


Herbert D. Kleber.

Levin FR, Lieberman JA, Pardes H.

Neuropsychopharmacology. 2019 Apr;44(5):1007. doi: 10.1038/s41386-019-0318-7. Epub 2019 Feb 4. No abstract available.


Development of a Cascade of Care for responding to the opioid epidemic.

Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M.

Am J Drug Alcohol Abuse. 2019;45(1):1-10. doi: 10.1080/00952990.2018.1546862. Epub 2019 Jan 24.


A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV.

Am J Psychiatry. 2019 Feb 1;176(2):129-137. doi: 10.1176/appi.ajp.2018.17070732. Epub 2018 Oct 19.


Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68].

Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.

J Subst Abuse Treat. 2018 Sep;92:99. doi: 10.1016/j.jsat.2018.06.015. Epub 2018 Jul 9. No abstract available.


Developing an opioid use disorder treatment cascade: A review of quality measures.

Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.

J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2. Erratum in: J Subst Abuse Treat. 2018 Sep;92:99.


How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.

Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J.

Drug Alcohol Depend. 2018 Jul 1;188:135-140. doi: 10.1016/j.drugalcdep.2018.03.043. Epub 2018 May 1.


Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.

Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR.

Addict Biol. 2018 Apr 16. doi: 10.1111/adb.12621. [Epub ahead of print]


Transcranial Magnetic Stimulation of Medial Prefrontal and Cingulate Cortices Reduces Cocaine Self-Administration: A Pilot Study.

Martinez D, Urban N, Grassetti A, Chang D, Hu MC, Zangen A, Levin FR, Foltin R, Nunes EV.

Front Psychiatry. 2018 Mar 16;9:80. doi: 10.3389/fpsyt.2018.00080. eCollection 2018.


Commentary: Providing technical assistance for the state targeted response for opioid use disorders: Time is of the essence.

Levin FR, Cates-Wessel K.

Am J Addict. 2018 Apr;27(3):158-160. doi: 10.1111/ajad.12705. Epub 2018 Mar 23. No abstract available.


International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group, Matthys F.

Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.


Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.

Brezing CA, Choi CJ, Pavlicova M, Brooks D, Mahony AL, Mariani JJ, Levin FR.

Am J Addict. 2018 Mar;27(2):101-107. doi: 10.1111/ajad.12660. Epub 2018 Feb 19.


Open-label pilot study of injectable naltrexone for cannabis dependence.

Notzon DP, Kelly MA, Choi CJ, Pavlicova M, Mahony AL, Brooks DJ, Mariani JJ, Levin FR.

Am J Drug Alcohol Abuse. 2018;44(6):619-627. doi: 10.1080/00952990.2017.1423321. Epub 2018 Feb 8.


Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder.

Luo SX, Wall M, Covey L, Hu MC, Scodes JM, Levin FR, Nunes EV, Winhusen T.

Am J Drug Alcohol Abuse. 2018;44(6):653-659. doi: 10.1080/00952990.2017.1416474. Epub 2018 Jan 25.


A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.

Dakwar E, Nunes EV, Hart CL, Hu MC, Foltin RW, Levin FR.

Neuropharmacology. 2018 Nov;142:270-276. doi: 10.1016/j.neuropharm.2018.01.005. Epub 2018 Jan 5.


The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.

Brezing CA, Levin FR.

Neuropsychopharmacology. 2018 Jan;43(1):173-194. doi: 10.1038/npp.2017.212. Epub 2017 Sep 6. Review.


A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.


Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.

Williams AR, Santaella-Tenorio J, Mauro CM, Levin FR, Martins SS.

Addiction. 2017 Nov;112(11):1985-1991. doi: 10.1111/add.13904. Epub 2017 Jul 17.

Supplemental Content

Loading ...
Support Center